# Yosemite Fund II

> Yosemite Fund II closed at $350M, as Reed Jobs told Fortune on November 4, 2026. January's $200M first close is included in this total; it is not an extra round. Named LPs include Amgen, AbbVie, MIT, Memorial Sloan Kettering and John Doerr. Exact legal close date and fees undisclosed.

## Profile

- **Stage-based planning range:** $100K–$1M
- **Check-size evidence basis:** estimated
- **Founded:** N/A
- **Headquarters:** San Francisco, USA
- **AUM:** N/A
- **Rounds they lead:** N/A
- **Rounds they invest:** N/A

## Links

- [Website](https://yosemite.co/)

## Research sources

- [Founder interview, Fortune, Nov 4 2026](https://fortune.com/2026/11/04/reed-jobs-yosemite-raises-350-million-second-fund-make-cancer-non-lethal/)

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/fund/yosemite-fund-ii